New TIF Guidelines for Emergency Care in Thalassaemia and SCD
Thalassaemia International Federation (TIF) shared a post on LinkedIn:
“TIF is delighted to announce the publication of the second edition of the ‘Guidelines for the Emergency Management of Thalassaemia and Sickle Cell Disease’.
Thoroughly revised, updated, and significantly expanded, this new edition builds on TIF’s pioneering 2012 publication while extending its scope to encompass Sickle Cell Disease alongside Thalassaemia.
At its heart lies the vital objective to help healthcare professionals respond swiftly, safely and confidently when a person living with a haemoglobin disorder requires Emergency Care.
The guide provides a practical and accessible framework for recognising potentially serious signs, symptoms and complications; undertaking appropriate initial assessments and investigations; initiating urgent management; and identifying when specialist involvement or escalation of care is required.
This landmark publication is the product of an extensive international collaboration, bringing together a distinguished multidisciplinary group of editors, authors and contributors whose collective expertise spans Haematology, Emergency Medicine and related fields.
TIF extends its sincere appreciation to every expert who contributed to this major undertaking.
A much-needed resource is now ready to support emergency physicians, nurses, haematologists, paediatricians, trainees and healthcare teams worldwide.
To access and download the full publication, please visit.”

Stay updated with Hemostasis Today.
-
Sep 26, 2026, 09:28Annette Bowyer: Rethinking Product Specific Calibrators in Haemophilia
-
Sep 26, 2026, 09:21Nisanth Menon: When Emergency Medicine Meets Transfusion Medicine
-
Sep 26, 2026, 07:50Giuseppe Andò: P2Y12 Inhibition in Diabetes – A Personalized Approach
-
Sep 26, 2026, 07:36Tiffany Hall: Honored to Be Recognized for Advancing Blood Health
-
Sep 26, 2026, 07:23Jignesh Patel: Call for Papers on Safer IV Unfractionated Heparin Use
-
Sep 26, 2026, 07:13Denise Braendgaard: OneSCD Brings Sickle Cell Disease to the Global Stage
-
Sep 26, 2026, 07:03Robert Tadevosyan: From Scientific Day to the Stago Factory
-
Sep 26, 2026, 07:01David McIntosh: Plasma Derived Medicines and the Global Access Gap
-
Sep 26, 2026, 06:49Heghine Khachatryan: Navigating the Complexities of Pediatric VTE